Event

MicroPort MedBot forecasts first half-year profit as Toumai overseas revenue grows

Jul 22, 2026 · Market Signal · MicroPort MedBot · Surgical

MicroPort MedBot issued a positive profit alert forecasting RMB28 million to RMB40 million in first-half profit, reversing a prior-year loss as revenue accelerated.

  • The company forecast first-half profit of roughly RMB28 million to RMB40 million versus a RMB115 million loss a year earlier.
  • Expected revenue growth was approximately 200% to 230% year over year.
  • MicroPort MedBot cited overseas Toumai surgical-robot revenue growth of more than 450%.

MicroPort MedBot is a Shanghai surgical-robotics company developing laparoscopic, orthopaedic, vascular-interventional and other robot-assisted procedure systems.

Segment
Surgical
Event type
Market Signal
Added to Korthos
Jul 23, 2026
Geography
Shanghai, Shanghai · CN